Published: January 27, 2026 at 2:08 pm
Evaro, an NHS-licensed digital healthcare platform serving over two million patients, has closed a Series A funding round of around £18 million.
The platform already partners with period-tracking app Clue and sexual wellness retailer Lovehoney, embedding prescription services directly into their customer experiences.
The Norwich-based firm says the round will accelerate Evaro’s healthcare-as-a-service model across three markets: consumer brands seeking new revenue streams, healthcare organisations expanding digital capacity, and employers deploying health benefits.